Literature DB >> 20967726

[Commentary to the article: Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomized controlled trials. Lancet Oncology, 2010; DOI:10.1016/S1470-2045(10)70106-6].

Lukasz Januszkiewicz1.   

Abstract

Entities:  

Year:  2010        PMID: 20967726

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  5 in total

1.  2011 Canadian Hypertension Education Program recommendations: an annual update.

Authors:  Norm Campbell
Journal:  Can Fam Physician       Date:  2011-12       Impact factor: 3.275

Review 2.  Advances on EGFR mutation for lung cancer.

Authors:  Giulio Metro; Lucio Crinò
Journal:  Transl Lung Cancer Res       Date:  2012-03

3.  ARBs and possible cancer risk.

Authors:  J Aalbers
Journal:  Cardiovasc J Afr       Date:  2010 Jul-Aug       Impact factor: 1.167

4.  Opinions in hypertension. ARBs and risk of cancer: international and South African expert comment.

Authors:  C Lombard; A Nosworthy; J Albers
Journal:  Cardiovasc J Afr       Date:  2010 Nov-Dec       Impact factor: 1.167

Review 5.  The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.

Authors:  Ethan J Kilmister; Swee T Tan
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.